ARTICLE | Clinical News
CXA-201: Phase II data
June 20, 2011 7:00 AM UTC
Top-line data from a double-blind, international Phase II trial in 122 patients showed that 1.5 g thrice-daily IV CXA-201 plus metronidazole led to a comparable clinical cure rate at the TOC visit 7-1...